EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

Physical activity is seen as a way to extend the human lifespan, but the benefits of physical...

Experiencing nature, even in the form of watching nature videos, can alleviate acute physical pain.

Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...

Content from other channels on our network

Linux is coming!

Bonfiglioli New Zealand cuts the ribbon at new premises

Thermal mass flowmeters: when is pressure compensation important?

Welding body calls for a nation‍-‍building approach to combat Trump's tariffs

Mars Wrigley to boost Asquith factory with new production line

Circularity needed at scale for Aust building industry

Textile recycler BlockTexx wins Gold for sustainability

Water shortages prompt Vic Government to boost supply

New chemistry extracts valuable compounds from plant waste

Coalition to scrap vehicle policy reducing emissions

First cell-cultured food approved by FSANZ Board

Bonfiglioli New Zealand opens its new premises in Auckland

MycoTechnology's flavour modifier achieves FEMA GRAS status

Lifting the lid on the benefits of sodium reduction legislation

CSIRO program to help advance WA's agrifood innovations